Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Pedersen

Showing results (181-190 of 183) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 183 results.
Journal of Bioenergetics and Biomembranes|July 27, 2016
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedsideJ Azevedo-Silva, O Queirós, F Baltazar, et al.
Medical Oncology (Northwood, London, England)|June 18, 2022
Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapyJ Azevedo-Silva, D Tavares-Valente, A Almeida, et al.
Scandinavian Journal of Rheumatology|November 17, 2018
Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patientsA E Secher, B Glintborg, H Gudbergsen, et al.
Pageof 19

Showing results (181-190 of 183) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 183 results.
Journal of Bioenergetics and Biomembranes|July 27, 2016
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedsideJ Azevedo-Silva, O Queirós, F Baltazar, et al.
Medical Oncology (Northwood, London, England)|June 18, 2022
Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapyJ Azevedo-Silva, D Tavares-Valente, A Almeida, et al.
Scandinavian Journal of Rheumatology|November 17, 2018
Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patientsA E Secher, B Glintborg, H Gudbergsen, et al.
Pageof 19